Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Extracellular Matrix Scaffold Using Decellularized Cartilage for Hyaline Cartilage Regeneration Publisher Pubmed



Monzavi SM1, 2 ; Kajbafzadeh AM1, 2 ; Sabetkish S1 ; Seifalian A3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Urology and Regenerative Medicine Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Nanotechnology and Regenerative Medicine Commercialization Centre (NanoRegMed Ltd.), The London BioScience Innovation Centre, London, United Kingdom
  4. 4. UCL Centre for Nanotechnology and Regenerative Medicine, Division of Surgery and Interventional Science, University College London, London, United Kingdom

Source: Advances in Experimental Medicine and Biology Published:2021


Abstract

The repair of osteochondral defects is among the top ten medical needs of humans in the 21st centuries with many countries facing rapidly aging population involved with osteoarthritis as a major contributor to global disease burden. Tissue engineering methods have offered new windows of hope to treat such disorders and disabilities. Regenerative approaches to cartilage injuries require careful replication of the complex microenvironment of the native tissue. The decellularized hyaline cartilage derived from human allografts or xenografts is potentially an ideal scaffold, simulating the mechanical and biochemical properties, as well as biological microarchitecture of the hyaline cartilage. There have been many attempts to regenerate clinically viable hyaline cartilage tissue using decellularized cartilage-derived extracellular matrix with stem cell technology. This chapter describes the reproducible methods for hyaline cartilage decellularization and recellularization. In addition, quality control and characterization requirements of the product at each step, as well as the clinical applications of final product have been discussed. © 2021, Springer Nature Switzerland AG.
Other Related Docs
13. Engineering Natural Heart Valves: Possibilities and Challenges, Journal of Tissue Engineering and Regenerative Medicine (2017)
17. Portable Hand-Held Bioprinters Promote in Situ Tissue Regeneration, Bioengineering and Translational Medicine (2022)